{
  "question_stem": {
    "en": "A 64-year-old man comes to the emergency department due to fever, anorexia, and nausea. He recently immigrated to the United States from Vietnam to live with his son. Several weeks ago, the patient was found to have a positive tuberculin skin test after a routine office visit. He had no respiratory symptoms, and a chest x-ray was unremarkable. A month ago, he started isoniazid therapy with pyridoxine supplementation. Today, his temperature is 38.3 C (100.9 F). On physical examination, there is mild abdominal discomfort. Laboratory studies are pending.",
    "zh": "一名64岁男性因发热、食欲不振和恶心来急诊科就诊。他最近从越南移民到美国，与他的儿子一起生活。几周前，在一次例行诊所就诊后，发现该患者的结核菌素皮肤试验呈阳性。他没有呼吸道症状，胸部X光片无异常。一个月前，他开始接受异烟肼治疗，并补充吡哆醇。今天，他的体温为38.3摄氏度（100.9华氏度）。体格检查显示有轻微的腹部不适。实验室检查结果待定。"
  },
  "question": {
    "en": "Which of the following is the most likely cause of this patient's current symptoms?",
    "zh": "以下哪项最可能是该患者目前症状的原因？"
  },
  "options": {
    "A": {
      "en": "Factitious disorder",
      "zh": "诈病"
    },
    "B": {
      "en": "Gastric mucosal damage",
      "zh": "胃黏膜损伤"
    },
    "C": {
      "en": "Hepatocyte damage",
      "zh": "肝细胞损伤"
    },
    "D": {
      "en": "Peripheral nerve damage",
      "zh": "周围神经损伤"
    },
    "E": {
      "en": "Serum sickness",
      "zh": "血清病"
    }
  },
  "correct_answer": "C",
  "explanation": {
    "en": "This patient's positive tuberculin skin test, lack of respiratory symptoms, and normal chest x-ray indicate LATENT TUBERCULOSIS INFECTION (LTBI). Treatment for LTBI typically involves a rifamycin-based regimen or ISONIAZID monotherapy (with pyridoxine added for those at high risk of peripheral neuropathy). This patient was treated with isoniazid and pyridoxine; he now returns a month later with fever, anorexia, and nausea, suggesting a medication side-effect.\n\nINH is directly HEPATOTOXIC. In 10%-20% of patients, INH causes acute, mild hepatic dysfunction, characterized by transient increases in serum aminotransferases (AST/SGOT, ALT/SGPT). This adverse effect usually occurs during the first 4-6 months of treatment, and, in most cases, liver function tests return to baseline with continued INH therapy. In rare instances (<1%), INH induces a frank HEPATITIS that causes a syndrome similar to viral hepatitis (eg, fever, anorexia, nausea, jaundice); this sometimes evolves into a severe form with progressive liver dysfunction and death.\n\n(Choice A) Factitious disorder is the intentional falsification or inducement of symptoms with the goal of assuming the sick role. It is unlikely in this patient, who should be evaluated for INH hepatotoxicity.\n\n(Choice B) Nonsteroidal anti-inflammatory drugs can cause gastric mucosal damage by inhibiting gastric prostaglandin production.\n\n(Choice D) Peripheral neuropathy is the other major side effect of INH therapy. Patients at high risk for peripheral neuropathy (eg, pregnancy, HIV, diabetes mellitus) are given supplemental pyridoxine, which significantly reduces risk. Pyridoxine does not alter risk of hepatitis, and peripheral neuropathy does not present with nausea, fever, and anorexia.\n\n(Choice E) Serum sickness drug hypersensitivity generally causes fever, urticaria, arthralgias, proteinuria, and lymphadenopathy 5-10 days after exposure to the drug (antigen). This patient does not have arthralgias or skin findings.\n\nEducational objective:\nIsoniazid can be directly hepatotoxic, causing acute, mild hepatic dysfunction in 10%-20% of patients and frank hepatitis (fever, anorexia, and nausea, sometimes progressing to hepatic failure) in a small percentage of patients.",
    "zh": "该患者的结核菌素皮肤试验阳性、无呼吸道症状和胸部X光片正常表明潜伏性结核感染（LTBI）。 LTBI的治疗通常包括利福霉素类方案或异烟肼单药治疗（对于周围神经病变高危人群，需加用吡哆醇）。 该患者接受了异烟肼和吡哆醇的治疗； 他现在一个月后回来，出现发烧、食欲不振和恶心，提示药物副作用。\n\nINH具有直接的肝毒性。 在10%-20%的患者中，INH会导致急性、轻度的肝功能障碍，其特征是血清氨基转移酶（AST/SGOT、ALT/SGPT）短暂升高。 这种不良反应通常发生在治疗的前4-6个月，并且在大多数情况下，肝功能测试在继续使用INH治疗后恢复到基线。 在极少数情况下（<1%），INH会诱发明显的肝炎，导致类似病毒性肝炎的综合征（例如，发烧、食欲不振、恶心、黄疸）； 这有时会演变成严重形式，出现进行性肝功能障碍和死亡。\n\n（选项A）诈病是有意伪造或诱发症状以达到扮演病人角色的目的。 在该患者中不太可能发生，应评估其INH肝毒性。\n\n（选项B）非甾体类抗炎药可通过抑制胃前列腺素的产生而引起胃黏膜损伤。\n\n（选项D）周围神经病变是INH治疗的另一个主要副作用。 对于周围神经病变高危患者（例如，妊娠、HIV、糖尿病），应补充吡哆醇，这可显著降低风险。 吡哆醇不会改变肝炎的风险，并且周围神经病变不会出现恶心、发烧和食欲不振。\n\n（选项E）血清病药物超敏反应通常在暴露于药物（抗原）后5-10天引起发热、荨麻疹、关节痛、蛋白尿和淋巴结病。 该患者没有关节痛或皮肤表现。\n\n教育目标：\n异烟肼可直接肝毒性，在10%-20%的患者中引起急性、轻度的肝功能障碍，在少数患者中引起明显的肝炎（发烧、食欲不振和恶心，有时进展为肝功能衰竭）。"
  },
  "summary": {
    "en": "This question tests knowledge of isoniazid (INH) induced hepatotoxicity, a common adverse effect of INH therapy for latent tuberculosis infection (LTBI). It requires recognizing the signs and symptoms of liver dysfunction in a patient recently started on INH.\n\nTo solve this question, consider the patient's recent immigration history, positive tuberculin skin test indicating LTBI, and the initiation of INH therapy. The new onset of fever, anorexia, and nausea after starting INH should raise suspicion for drug-induced hepatotoxicity.",
    "zh": "本题考察了异烟肼（INH）诱导的肝毒性的知识，这是用于治疗潜伏性结核感染（LTBI）的INH治疗的常见不良反应。它需要识别最近开始使用INH的患者中肝功能障碍的体征和症状。\n\n要解决这个问题，请考虑患者最近的移民史，表明LTBI的结核菌素皮肤试验阳性，以及INH治疗的开始。开始使用INH后新发的热、食欲不振和恶心应引起对药物引起的肝毒性的怀疑。"
  },
  "tags": "Isoniazid; Hepatotoxicity; Latent tuberculosis infection; Liver disease; Drug-induced liver injury; Infectious diseases; Pharmacology",
  "category": "Micro",
  "question_id": "1774",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\1774",
  "extracted_at": "2025-11-05T15:02:07.921394",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:10:22.409317",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}